HORMONE-REFRACTORY PROSTATE CANCER

Clinical trials for HORMONE-REFRACTORY PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new HORMONE-REFRACTORY PROSTATE CANCER trials appear

Sign up with your email to follow new studies for HORMONE-REFRACTORY PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New hope for tough prostate cancers: first human trial begins

Disease control Recruiting now

This is the first human study testing an experimental drug called VIR-5500 for advanced prostate cancer that has stopped responding to standard treatments. Researchers will enroll 390 men to check if the drug is safe, how it moves through the body, and whether it shows early sign…

Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER

Phase: PHASE1 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

HORMONE-REFRACTORY PROSTATE CANCER

Get alerted when new HORMONE-REFRACTORY PROSTATE CANCER trials appear

New hope for tough prostate cancers: first human trial begins